IN2013MN00513A - - Google Patents

Download PDF

Info

Publication number
IN2013MN00513A
IN2013MN00513A IN513MUN2013A IN2013MN00513A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A IN 513MUN2013 A IN513MUN2013 A IN 513MUN2013A IN 2013MN00513 A IN2013MN00513 A IN 2013MN00513A
Authority
IN
India
Prior art keywords
monoclonal antibody
antigen
fragment
bonded
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Shuji Sato
Takeshi Goto
Shigeru Goto
Toshiaki Nakano
Naoya Ohmori
Kueichen Chiang
Yayoi Shimada
Kenji Mori
Takamitsu Miyagi
Original Assignee
Josai University Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Josai University Corp filed Critical Josai University Corp
Publication of IN2013MN00513A publication Critical patent/IN2013MN00513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN513MUN2013 2010-08-20 2011-08-19 IN2013MN00513A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010185406 2010-08-20
PCT/JP2011/068793 WO2012023614A1 (fr) 2010-08-20 2011-08-19 Anticorps monoclonal présentant une activité immunosuppressive ainsi que fragment se fixant à cet anticorps

Publications (1)

Publication Number Publication Date
IN2013MN00513A true IN2013MN00513A (fr) 2015-06-12

Family

ID=45605266

Family Applications (1)

Application Number Title Priority Date Filing Date
IN513MUN2013 IN2013MN00513A (fr) 2010-08-20 2011-08-19

Country Status (9)

Country Link
US (1) US9701739B2 (fr)
EP (1) EP2631246B1 (fr)
JP (1) JP5960596B2 (fr)
KR (1) KR101863978B1 (fr)
CN (1) CN103534271B (fr)
IN (1) IN2013MN00513A (fr)
RU (1) RU2559550C2 (fr)
TW (1) TWI449710B (fr)
WO (1) WO2012023614A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5960596B2 (ja) 2010-08-20 2016-08-02 学校法人 城西大学 免疫抑制活性を有するモノクローナル抗体またはその抗原結合断片
KR102119840B1 (ko) 2011-07-11 2020-06-09 아이크노스 사이언스 에스. 아. Ox40에 결합하는 항체 및 이들의 용도
JP2015117181A (ja) * 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤
CN104994875B (zh) * 2013-02-15 2018-10-09 免疫医疗公司 嵌合和人源化抗组蛋白抗体
JPWO2013125687A1 (ja) * 2013-02-22 2015-07-30 学校法人 城西大学 炎症疾患治療剤
CN105850770A (zh) * 2016-05-16 2016-08-17 贾文龙 一种宠物接便器

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098281A1 (fr) * 1990-12-17 1992-06-18 Howard M. Dintzis Freinage des reponses immunitaires a l'aide de formes oligomeres d'antigenes dont les proprietes chimiques sont determinees
JP2004014950A (ja) 2002-06-10 2004-01-15 Nippon Tungsten Co Ltd Ｐｔｃ特性を有するセラミックス材料
US20040052780A1 (en) 2002-09-05 2004-03-18 Hisamitsu Pharmaceutical Co., Inc. Immunosuppresants
JP2004149507A (ja) 2002-09-05 2004-05-27 Hisamitsu Pharmaceut Co Inc 免疫抑制剤
WO2006025580A1 (fr) 2004-09-03 2006-03-09 Amateraspharma Inc. Anticorps monoclonal anti-histone h1 et hybridome capable de produire ledit anticorps
WO2009001673A1 (fr) 2007-06-26 2008-12-31 Josai University Corporation Immunoadjuvant contenant de l'atp
JPWO2009004900A1 (ja) 2007-06-29 2010-08-26 学校法人 城西大学 ユビキノン含有免疫アジュバント
US20100324469A1 (en) 2007-10-04 2010-12-23 Josai University Corporation Drug product, a method of administrating a vaccine using the drug product, and an apparatus for iontophoresis
EP2209485B1 (fr) 2007-11-06 2016-03-30 Oklahoma Medical Research Foundation Histones extracellulaires en tant que biomarqueurs pour un pronostic et cibles moléculaires pour une thérapie
JP5960596B2 (ja) 2010-08-20 2016-08-02 学校法人 城西大学 免疫抑制活性を有するモノクローナル抗体またはその抗原結合断片
KR102119840B1 (ko) * 2011-07-11 2020-06-09 아이크노스 사이언스 에스. 아. Ox40에 결합하는 항체 및 이들의 용도
JP2015117181A (ja) 2012-02-22 2015-06-25 学校法人 城西大学 敗血症治療剤

Also Published As

Publication number Publication date
KR20130137612A (ko) 2013-12-17
CN103534271A (zh) 2014-01-22
EP2631246B1 (fr) 2016-07-20
EP2631246A4 (fr) 2014-01-15
JPWO2012023614A1 (ja) 2013-12-12
CN103534271B (zh) 2016-06-22
TW201300416A (zh) 2013-01-01
RU2013112324A (ru) 2014-09-27
US20140010815A1 (en) 2014-01-09
KR101863978B1 (ko) 2018-06-01
WO2012023614A1 (fr) 2012-02-23
TWI449710B (zh) 2014-08-21
US9701739B2 (en) 2017-07-11
EP2631246A1 (fr) 2013-08-28
RU2559550C2 (ru) 2015-08-10
JP5960596B2 (ja) 2016-08-02

Similar Documents

Publication Publication Date Title
NZ610267A (en) A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
WO2013059885A3 (fr) Produits de recombinaison de polypeptide et utilisations de ceux-ci
NZ597692A (en) Anti-IGF antibodies
NZ607969A (en) Cd33 binding agents
RU2018132044A (ru) Антитела против тау
MX2014001375A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2010004660A (es) NUEVOS ANTICUERPOS ESPECIFICOS DE LOS PEPTIDOS ß-AMILOIDES Y SUS USOS COMO AGENTES DE DIAGNOSTICO Y DROGAS.
WO2012051498A3 (fr) Anticorps qui lient des oligomères amyloïdes
NZ703653A (en) Anti-fap antibodies and methods of use
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
IN2014KN01715A (fr)
NZ612312A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
WO2010129895A3 (fr) Epitopes des cd133
MX341309B (es) Anticuerpos especificos del heterodimero de anti-il-23.
MX2011008759A (es) Medios y metodos para fabricar neurotoxina altamente pura.
WO2012091564A3 (fr) Polypeptide de réticulation induisant l'apoptose
WO2012047732A3 (fr) Compositions d'anticorps et procédés d'utilisation
NZ607615A (en) Antibodies directed against il-17
MX2015007421A (es) Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas.
EA201270701A1 (ru) Ингибирующие металлопротеины антитела
MY166152A (en) Anti-human xcr1 antibodies
GB2517354A (en) Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
IN2014DN07875A (fr)